Case Studies

Every drug development journey encounters challenges—but the right expertise can make all the difference. At KreaMedica, we help teams navigate complexity, manage risk, and keep timelines on track. Our flexible, proactive support has helped clients solve problems across toxicology, bioanalytics, and preclinical development—learn how we can help you do the same.

How KreaMedica Enabled Cost-Effective, Remote Toxicology Studies for Cairn Therapeutics

Cairn Therapeutics is a pharmaceutical company with a mission to help patients beat cancer. Its team is developing a novel drug for solid tumors and

Knowing When to Let Go of a Project: A Case Study with Adamed Pharma

Adamed Pharma is a leading pharmaceutical and biotechnology company, with over 900 products and 256 patents covering 19 therapeutic areas. It was the first Polish

Building Lasting Biotech Partnerships: An Interview with Ron Wolff of RK Wolff Safety Consulting

Ron Wolff, president of RK Wolff Safety Consulting Inc. and former Vice President of Regulatory Affairs & Toxicology at Pulmokine, is a long-time collaborator of

N-Zyme’s Path to the Clinic

Franco Vigile had recently sold the genetic-based pre-screening company he founded and was in Mexico celebrating when he woke up one morning unable to swallow.

Download the compiled Case Study PDF here

Testimonials

Don’t take our word for it.

James L. Ellis
CSO, Nocion Therapeutics, Inc.

They provided valuable insights and recommendations while seamlessly integrating into our team.

I have had the pleasure of working with KreaMedica on several programs. They proactively identified and addressed issues and provided regular updates to ensure everyone was on the same page. Their attention to detail and willingness to take ownership of the project’s success makes them invaluable partners. They are great to work with, and I would highly recommend them to anyone looking for a drug development partner.

Brian Jones
COO, Respirion Pharmaceuticals

KreaMedica was an essential complement to our virtual team.

They supplemented and filled in gaps in our internal network and worked well with our advisors. They truly wanted to contribute to and be part of the project’s success. I highly recommend Claude, Poulomee, and Rudi as reliable partners for planning and executing toxicological and bioanalytical projects.

Ron Wolff
RK Wolff Safety Consulting Inc., Principal

The combination of all their perspectives made a tremendous difference.

I have worked with KreaMedica for many years, and I must credit them for the team’s talent, professionalism, and chemistry. That doesn’t happen by accident. As a consultant, I rely on them as the first line to monitor studies and provide proactive solutions when required.

Tom Fritz
COO, Cairn Therapeutics

I don’t really know how we would have completed the project without KreaMedica under all the circumstances.

KreaMedica was instrumental in managing the preparation of the study reports, as well as editing and support. When we got the report, it had been
substantially refined and cleaned up, which helped to expedite the process.

Marcin Kołaczkowski
Lead CNS Scientist, Adamed Pharma

What KreaMedica provided was the resolve to say, ‘No, this is not going to work,’ even when we were emotionally invested.

KreaMedica helped us identify critical developability issues in several of our drug candidates and helped us make difficult choices that led to the right
candidate selection. We had to ‘kill’ several molecules, and we were ultimately really happy to have KreaMedica’s assistance in making those decisions.

Download Our Case Study Package

Download